Perrigo launches generic Aleve Liquid Gels

Editorial Checklist Reviewed
PerrigoNov 29 2010NewsGuard 100/100 Score

Perrigo (Nasdaq: PRGO; TASE) today announced that it has launched Naproxen Sodium Soft Gels. The product is the generic equivalent of Bayer HealthCare's Aleve® Liquid Gels, 220mg, an OTC analgesic.  Aleve® Liquid Gels had sales of approximately $80 million, as measured by Information Resources, Inc. Perrigo believes it is the first to market a store brand version of this product.

Perrigo's Chairman and CEO Joseph C. Papa stated, "This approval is another example of Perrigo's commitment to bring new products to market. Perrigo is working every day to make quality healthcare more affordable."

Source:

Perrigo

Posted in: Pharmaceutical News

Tags: ,

Comments (0)

Suggested Reading

Empowering lived experience in healthcare research
Exploring AI's role in transforming healthcare diagnosis and treatment
Enhancing the adoption of pragmatic clinical trial results in healthcare systems
Study reveals AI's potential and pitfalls in medical diagnosis
Review highlights advances in flexible optoelectronics for cardiac healthcare
Non-Hispanic Black children and low-income youth disadvantaged in concussion care
FDA strengthens AI regulation to ensure patient safety and innovation in healthcare
POINT project launches video to showcase its healthcare advancements

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
AI tools improve maternity care outcomes for women